|Gross Div Yield||0.000%|
Investment in established biotechnology businesses.
There are no upcoming dividends in this security at this time.
|Rubicon's Half Year Report 2013-2014||24 Mar 2014, 4:10pm||INTERIM|
|Ongoing Disclosure Notice - Luke Moriarty||24 Mar 2014, 3:14pm||RELINT|
|Ongoing Disclosure Notice - Mark Taylor||20 Mar 2014, 5:08pm||RELINT|
|Ongoing Disclosure Notice - Luke Moriarty||20 Mar 2014, 5:07pm||RELINT|
|Rubicon Interim Review for the Six Months Ended...||28 Feb 2014, 4:55pm||HALFYR|
The shares were listed in March 2001 as part of a recapitalisation of Fletcher Challenge Forests, and to acquire certain assets from Fletcher Challenge Energy. These included 594,000 ordinary shares in NASDAQ listed Capstone Turbine Corporation and the Challenge retail service station network in NZ. All of these interests were later sold...(more)
This information was provided by Rubicon Limited in their Full Year Report released on 29 August 2013: 2013 highlights included - Recovery in the US housing market, which lifted forest harvesting (and replanting); - 273 million ArborGen seedlings sold in the US and Australasia - up 9.5% on 2012; - Revenue increased 14% year-on-...(more)